Divisão de Urologia, Faculdade de Medicina da Universidade de São Paulo, Instituto do Câncer de Estado de São Paulo, São Paulo, Brazil.
Divisão de Urologia, Faculdade de Medicina da Universidade de São Paulo, Instituto do Câncer de Estado de São Paulo, São Paulo, Brazil.
Clin Genitourin Cancer. 2022 Apr;20(2):102-106. doi: 10.1016/j.clgc.2021.10.009. Epub 2021 Nov 22.
To evaluate the association of neutrophil-to-lymphocyte ratio (NLR) with recurrence-free survival (RFS) and overall survival (OS) in patients with locally advanced nonmetastatic clear cell renal cell carcinoma (ccRCC) undergoing radical nephrectomy.
We retrospectively identified 880 nephrectomies performed between January 2009 and December 2016 in a single center, reviewed data from 478 radical nephrectomies for kidney tumors and identified 187 patients with locally advanced nonmetastatic ccRCC (pT3-T4 N0M0). NLR was obtained preoperatively and calculated by dividing absolute neutrophil count by absolute lymphocyte count. OS and RFS were evaluated by the Kaplan-Meier method. Cox proportional-hazards regression models were used to evaluate predictors of RFS and OS.
Among 187 patients with ccRCC (mean age 63.4 ± 11.5 years; 118 [63.1%] male), the median follow-up was 48.7 months. On univariate analysis, in patients with Fuhrman nuclear grade of differentiation 3-4, the median time to recurrence was significantly shorter with NLR ≥ 4 than < 4 (24 vs. 55 months, P = .045). On multivariable analysis adjusted for NLR ≥ 4, among all variables analyzed (NLR, microvascular invasion, sarcomatoid differentiation, tumor size and body mass index), only nuclear grade of differentiation was an independent predictor of recurrence (hazard ratio 2.18; 95% confidence interval 1.07-4.92, P = .03). The 3-year OS had no statistically significant difference between patients with NLR ≥ 4 or < 4.
For patients with locally advanced, nonmetastatic ccRCC, RFS was reduced with high nuclear grade of differentiation and high preoperative NLR. These findings suggest an association between higher NLR and worse outcomes in locally advanced ccRCC.
评估中性粒细胞与淋巴细胞比值(NLR)与局部进展性非转移性透明细胞肾细胞癌(ccRCC)患者接受根治性肾切除术后无复发生存(RFS)和总生存(OS)的关系。
我们回顾性地确定了 2009 年 1 月至 2016 年 12 月在一个中心进行的 880 例肾切除术,对 478 例肾肿瘤根治性肾切除术的数据进行了回顾,并确定了 187 例局部进展性非转移性 ccRCC(pT3-T4 N0M0)患者。术前获得 NLR,通过绝对中性粒细胞计数除以绝对淋巴细胞计数计算。通过 Kaplan-Meier 方法评估 OS 和 RFS。Cox 比例风险回归模型用于评估 RFS 和 OS 的预测因素。
在 187 例 ccRCC 患者中(平均年龄 63.4 ± 11.5 岁;118 [63.1%] 为男性),中位随访时间为 48.7 个月。在单因素分析中,在核分化程度为 3-4 级的患者中,NLR≥4 与 NLR<4 的中位复发时间显著缩短(24 与 55 个月,P=0.045)。在多变量分析中,在调整 NLR≥4 后,在分析的所有变量(NLR、微血管侵犯、肉瘤样分化、肿瘤大小和体重指数)中,只有核分化程度是复发的独立预测因素(风险比 2.18;95%置信区间 1.07-4.92,P=0.03)。NLR≥4 或 NLR<4 的患者 3 年 OS 无统计学差异。
对于局部进展性、非转移性 ccRCC 患者,高核分化程度和高术前 NLR 与 RFS 降低有关。这些发现表明 NLR 升高与局部进展性 ccRCC 预后不良之间存在关联。